摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

(E)-2-(2-(thiophen-2-yl)vinyl)-1H-benzo[d]imidazole | 63405-66-3

中文名称
——
中文别名
——
英文名称
(E)-2-(2-(thiophen-2-yl)vinyl)-1H-benzo[d]imidazole
英文别名
trans-2-(2-Thien-2-ylvinyl)benzimidazol;1H-benzimidazole, 2-[2-(2-thienyl)ethenyl]-;2-[(E)-2-thiophen-2-ylethenyl]-1H-benzimidazole
(E)-2-(2-(thiophen-2-yl)vinyl)-1H-benzo[d]imidazole化学式
CAS
63405-66-3
化学式
C13H10N2S
mdl
——
分子量
226.302
InChiKey
HHXISSOUHFCYCU-BQYQJAHWSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    3.5
  • 重原子数:
    16
  • 可旋转键数:
    2
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.0
  • 拓扑面积:
    56.9
  • 氢给体数:
    1
  • 氢受体数:
    2

反应信息

  • 作为产物:
    描述:
    2-噻吩甲醛copper(l) iodide溶剂黄146 、 sodium hydroxide 作用下, 以 乙醇 为溶剂, 反应 1.0h, 生成 (E)-2-(2-(thiophen-2-yl)vinyl)-1H-benzo[d]imidazole
    参考文献:
    名称:
    α-Aroylidineketene dithioacetal chemistry: CuI catalyzed synthesis of 2-styryl benzimidazoles enroute to regioselective hydrothiolation
    摘要:
    Reactivity of alpha-aroylidineketene dithioacetals 2 was investigated to synthesize novel 2-styrylbenzimidazole derivatives 4 and their hydrothiolated product 2-(2-(methylthio)-2-arylethyl)-1H-benzoidlimidazoles 5 has been reported. Compounds 4 and 5 were synthesized by cyclocondensation of alpha-aroylidineketene dithioacetals 2 and o-phenylene diamine (OPD) 3 in the presence and absence of copper catalyst respectively. Regioselective one-pot tandem hydrothiolation of olefin functionality in 4 was achieved under AcOH conditions. (C) 2015 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.tet.2015.06.008
点击查看最新优质反应信息

文献信息

  • SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY
    申请人:Panicker Bijoy
    公开号:US20110237633A1
    公开(公告)日:2011-09-29
    The present invention provides compounds and pharmaceutically acceptable compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which hepatocyte growth factor/scatter factor (HGF/SF) or the activities thereof, or agonists or antagonists thereof, have a therapeutically useful role.
    本发明提供化合物及其药学上可接受的组合物,以及使用它们治疗一系列疾病或病症的方法,其中包括肝细胞生长因子/散发因子(HGF/SF)或其活性,或其激动剂或拮抗剂在治疗中具有治疗作用。
  • [EN] SMALL MOLECULE MODULATORS OF HEPATOCYTE GROWTH FACTOR (SCATTER FACTOR) ACTIVITY<br/>[FR] MODULATEURS À PETITES MOLÉCULES DE L'ACTIVITÉ DU FACTEUR DE CROISSANCE (FACTEUR DE DISPERSION) DES HÉPATOCYTES
    申请人:ANGION BIOMEDICA CORP
    公开号:WO2010068287A2
    公开(公告)日:2010-06-17
    The present invention provides compounds and pharmaceutically acceptable compositions thereof, and methods for the use thereof for the treatment of any of a number of conditions or diseases in which hepatocyte growth factor/scatter factor (HGF/SF) or the activities thereof, or agonists or antagonists thereof, have a therapeutically useful role.
查看更多